All Posts Tagged With: "CAH"
(CAH) Cardinal Health Analyst Maintains Outperform on Shares
We reiterate our Outperform rating on Cardinal Health (CAH). Its first-quarter fiscal 2012 (ended September 30) adjusted earnings per share of 73 cents beat the Zacks Consensus Estimate of 72 cents. Earnings from continuing operations (as reported) dropped about 19% year over...
7Dec2011 | vitalstocks | 0 comments | Continued(OMCL) Omnicell Beats Estimates
Omnicell Inc. (OMCL) reported EPS of 9 cents during the second quarter of fiscal 2011, beating both the Zacks Consensus Estimate of 8 cents and the year-ago quarter EPS of 4 cents. Reported earnings shot up 125% on a year-over-year basis primarily due to the reduction in effective...
4Nov2011 | vitalstocks | 0 comments | Continued(CAH) Cardinal Health Incorporated – Bull of the Day
We recently upgraded our rating on Cardinal Health, Inc. (CAH) to Outperform. Earnings for the fourth quarter narrowly beat the Zacks Consensus Estimate. Cardinal’s size and diversity partly insulate it from economic cycles, and its generics business continues to grow at...
7Oct2011 | vitalstocks | 0 comments | Continued(CAH) Cardinal Health Incorporated – Bull of the Day
We upgrade our rating on Cardinal Health, Inc. (CAH) to Outperform. Earnings for the fourth quarter narrowly beat the Zacks Consensus Estimate. Cardinal’s size and diversity partly insulate it from economic cycles. Its generics business continues to grow at a healthy pace. Moreover,...
3Oct2011 | vitalstocks | 0 comments | Continued(OMCL) Omnicell Analyst Maintains Neutral on Shares
We recently reiterated our Neutral recommendation on Omnicell (OMCL) with a target price of $16.00. Omnicell reported an adjusted EPS of 8 cents in the second quarter of fiscal 2011, beating both the Zacks Consensus Estimate and the year-ago quarter’s EPS of 6 cents. Total...
20Sep2011 | vitalstocks | 0 comments | Continued(WAG) Walgreen in Elite League
Recently, Walgreen (WAG) was ranked 29th among the top 30 technology innovators in the U.S, according to the 2011 Information Week 500. The company added another feather in its cap when it became the top-ranked company in the retail and general merchandising category. The company...
20Sep2011 | vitalstocks | 0 comments | Continued(WAG) Walgreen Ranked as Technology Innovator
Recently, Walgreen (WAG) was ranked 29th among the top 30 technology innovators in the U.S, according to the 2011 InformationWeek 500. The company added another feather in its cap when it became the top-ranked company in the retail and general merchandising category. The company...
15Sep2011 | vitalstocks | 0 comments | Continued(ABC) AmerisourceBergen Analyst Reiterates Neutral on Shares
We recently reiterated our Neutral recommendation on AmerisourceBergen Corporation (ABC) with a target price of $40.00. Over the last several years, the company has been benefiting from the growth of the pharmaceutical industry in the US. We believe AmerisourceBergen should continue...
26Aug2011 | vitalstocks | 0 comments | Continued(OMCL) Omnicell’s Electronic Health Record Wins Certification
Omnicell, Inc. (OMCL), a leading developer and marketer of end-to-end automation solutions for the medication-use process, recently announced that its newly launched G4 platform received the ONC-ATCB certification as a Modular Electronic Health Record (“EHR”). Omnicell...
22Jun2011 | vitalstocks | 0 comments | Continued(OMCL) Omnicell Earns Second Consecutive Best in Klas Award
Omnicell (OMCL), recently announced that it has received recognition for its OmniRx automated dispensing system from leading research firm, KLAS for the second consecutive year. Along with the 2011 “Best in KLAS” award for Automated Medication Dispensing Units for...
19Jun2011 | vitalstocks | 0 comments | Continued(CAH) Cardinal Health Third Quarter 2011 Earnings Preview
Cardinal Health (CAH) is slated to report its third-quarter fiscal 2011 (ending March) results on Thursday, April 28. The company expects earnings per share in the range of $2.54 to $2.60 for fiscal 2011. The current Zacks Consensus Estimate for revenues and earnings for the...
27Apr2011 | vitalstocks | 0 comments | Continued(WPI) Watson Pharmaceuticals Analyst Maintains Neutral Rating on Shares
We recently reaffirmed our Neutral stance on Watson Pharmaceuticals Inc. (WPI) following the release of fourth quarter and fiscal year 2010 financial results. Quarterly earnings of 93 cents per share were in line with the Zacks Consensus Estimate and 8 cents above the year-ago...
17Mar2011 | vitalstocks | 0 comments | Continued(CAH) Cardinal Health Gets Antitrust Clearance
Cardinal Health (CAH) recently announced that antitrust regulators had cleared its $1.3 billion takeover of Kinray, a leading pharma distributor with a presence in the New York metropolitan area. In this regard, the Federal Trade Commission (“FTC”) had approved early termination...
20Dec2010 | vitalstocks | 0 comments | Continued(CAH) Cardinal Health Announces Buy of Kinray
Cardinal Health (CAH) recently announced plans to purchase Kinray Inc., a leading pharma distributor with a presence in the New York metropolitan area. The cash deal will enhance Cardinal’s capability to cater to retail independent pharmacies in the northeastern U.S. markets....
19Dec2010 | vitalstocks | 0 comments | Continued(CAH) Cardinal Health Prepares for Coming Flu Season
Cardinal Health (CAH) is taking necessary steps to maintain the supply of influenza vaccines during the forthcoming 2010-2011 flu season. For the first time, the Advisory Committee on Immunization Practices (ACIP) has been asking everyone over 6 months of age to get a flu vaccine....
3Oct2010 | vitalstocks | 0 comments | Continued(CAH) Cardinal Health Sells Remaining CareFusion Shares
Cardinal Health (CAH), a leading distributor of pharmaceuticals and medical supplies, recently sold off the remaining 30.5 million shares of CareFusion Corporation (CFN) for $705.9 million. CareFusion, a San Diego-based vendor for medical equipment and infection control supplies,...
19Sep2010 | vitalstocks | 0 comments | Continued(CAH) Cardinal Health and Cumberland Pharmaceuticals Sign Deal
Cardinal Health (CAH), one of the largest distributors of pharmaceuticals and medical supplies, has reportedly inked a distribution agreement with Nashville, Tennessee-based Cumberland Pharmaceuticals (CPIX), a specialty pharmaceutical firm focused on the acute-care hospital...
22Aug2010 | vitalstocks | 0 comments | Continued(CAH) Cardinal Health and Cumberland Pharmaceuticals Sign Deal
Cardinal Health (CAH), one of the largest distributors of pharmaceuticals and medical supplies, has reportedly inked a distribution agreement with Nashville, Tennessee-based Cumberland Pharmaceuticals (CPIX), a specialty pharmaceutical firm focused on the acute-care hospital...
18Aug2010 | vitalstocks | 0 comments | Continued(CAH) Cardinal Health Earnings Scorecard
Cardinal Health (CAH), one of the largest distributors of pharmaceuticals and medical supplies, recently reported earnings for fourth-quarter of fiscal year 2010, which beat the Zacks Consensus Estimate by a penny. Revenues grew by a mere 0.5% year over year to $22.3 billion....
11Aug2010 | vitalstocks | 0 comments | Continued(CAH) Cardinal Health Analyst Reaffirms Neutral Rating
We maintain our Neutral recommendation for Cardinal Health (CAH), one of the largest distributors of pharmaceuticals and medical supplies. Earnings for fourth-quarter fiscal 2010 beat the Zacks Consensus Estimate by a penny. However, profit dipped year-over-year, impacted by...
10Aug2010 | vitalstocks | 0 comments | Continued(CAH) Cardinal Health’s Report Beats Expectations by a Penny
Cardinal Health (CAH) reported fourth-quarter and fiscal 2010 adjusted (excluding one-time expenses) earnings per share of 50 cents and $2.22 respectively, exceeding the Zacks Consensus Estimates of 49 cents and $2.21, respectively, but below the year-ago results of 63 cents...
6Aug2010 | vitalstocks | 0 comments | Continued(CAH) Cardinal Health – Increased Dividend by 11%
Cardinal Health (CAH) is in a stable industry with steady revenues and a safe dividend. Growth and Income The company is expected to grow its EPS 10.8% over the next three to five years. The stock also offers investors a dividend yield of 2.3%. This Zacks #2 Rank stock trades...
6Aug2010 | vitalstocks | 0 comments | Continued(CAH) Cardinal Health Earnings Preview
Cardinal Health (CAH) is slated to report fourth-quarter and fiscal 2010 (ending June 30, 2010) results on Thursday, August 5, 2010. The company earlier issued earnings per share guidance in the range of $2.15 to $2.20 for fiscal 2010. The current Zacks Consensus Estimate for...
2Aug2010 | vitalstocks | 0 comments | Continued(CAH) Cardinal Health Quarterly Earnings Outperform
Cardinal Health, Inc. (CAH) reported third quarter fiscal 2010 earnings per share of 61 cents, outperforming the Zacks Consensus Estimate of 57 cents. However, earnings were lower than the year-ago figure of 66 cents. Sales Total sales in the third quarter increased 1% year over...
30Apr2010 | vitalstocks | 0 comments | Continued(ABC) AmerisourceBergen Beats Forecasts – Raises Outlook Again
AmerisourceBergen Corp. (ABC) posted second quarter fiscal 2010 earnings of 63 cents per share, beating the Zacks Consensus Estimate by 8 cents. Earnings increased 34% from the year-ago period. Performance was driven by strong revenues, successful generic drug launches, and continued...
22Apr2010 | vitalstocks | 0 comments | Continued(CFN) CareFusion Decides to Acquire Medegen for $225 Million
CareFusion Corporation (CFN) has decided to acquire Medegen for $225 million in cash. CareFusion expects the acquisition to be neutral to the adjusted earnings per share in the first year of operations and increasingly accretive thereafter. The acquisition is expected to be completed...
7Apr2010 | vitalstocks | 0 comments | Continued(PBR) U.S. Consumer Price Index Remains Tame
We got more evidence today that inflation is not a serious concern. The Consumer Price Index (CPI) was unchanged in February after five straight months when it had increased by only 0.2% per month. Overall consumer prices are just 2.1% higher than a year ago. If food and energy...
18Mar2010 | vitalstocks | 0 comments | Continued(CAH) Cardinal Health – Earnings Estimates Are Moving Higher
Cardinal Health (CAH) provides investors with 10% earnings growth and a dividend yield of 2%. Company Description Cardinal Health is one of the largest distributors of pharmaceuticals and medical supplies. The company is also a leading provider of products and services that improve...
3Mar2010 | vitalstocks | 0 comments | Continued(CFN) CareFusion Corporation Beats Consensus Estimates
CareFusion Corporation (CFN) recently reported second quarter fiscal 2010 earnings per share of 39 cents, marginally beating the Zacks Consensus Estimate of 38 cents, but lower than the year-ago earnings of 50 cents. Total revenues in the second quarter increased 5% year over...
10Feb2010 | vitalstocks | 0 comments | Continued(CAH) Cardinal Health Upgraded to Outperform
We have recently upgraded Cardinal Health Inc. (CAH) to “Outperform” with a target price of $37 based on approximately 15.7x our fiscal 2011 EPS estimate of $2.36. Cardinal Health reported second quarter fiscal 2010 earnings per share of 57 cents, beating the Zacks Consensus...
10Feb2010 | vitalstocks | 0 comments | Continued